about
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferationEpigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.Fluorescence lifetime imaging distinguishes basal cell carcinoma from surrounding uninvolved skin.Reducing the learning curve for the treatment of morphoeic (sclerosing) basal cell carcinoma of the face.Basal cell carcinoma of the head and neck region: a retrospective analysis of completely excised 331 cases.The dermatoscopic universe of basal cell carcinomaImmunohistochemical analysis of the mechanistic target of rapamycin and hypoxia signalling pathways in basal cell carcinoma and trichoepithelioma.The Hedgehog signalling pathway and cancer.Different Anatomical Distribution of Basal Cell Carcinoma Subtypes in Iranian Population: Association between Site and SubtypeBasal cell carcinoma: a dermatopathological and molecular biological update.Correlation of Global MicroRNA Expression With Basal Cell Carcinoma Subtype.Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions.Molecular aetiology and pathogenesis of basal cell carcinoma.Surgical treatment of basal cell carcinomas using standard postoperative histological assessment.Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas.Clear cell basal cell carcinoma with sialomucin deposition.Characteristics of Mixed Type Basal Cell Carcinoma in Comparison to Other BCC Subtypes.Basal cell carcinoma - diagnosis.Hereditary tumour syndromes featuring basal cell carcinomas.Is There a Relationship between the Stratum Corneum Thickness and That of the Viable Parts of Tumour Cells in Basal Cell Carcinoma?Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.Mohs micrographic surgery for periocular skin tumours in Ireland.Diagnostic accuracy of confocal microscopy imaging vs. punch biopsy for diagnosing and subtyping basal cell carcinoma.Role of CRD-BP in the growth of human basal cell carcinoma cells.Reporting basal cell carcinoma: a survey of the attitudes of histopathologists.Association between Toll-like receptor 7 Gln11Leu single-nucleotide polymorphism and basal cell carcinoma.Basal cell carcinoma: an updated epidemiological and therapeutically profile of an urban population.Usefulness of margin detection by digital dermoscopy in the traditional surgical excision of basal cell carcinomas of the head and neck including infiltrative/morpheaform type.Nuclear morphometry and chromatin textural characteristics of basal cell carcinoma.Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1 alpha-directed invasion of human basal cell carcinoma cells.Preoperative prediction of histopathological outcome in basal cell carcinoma: flat surface and multiple small erosions predict superficial basal cell carcinoma in lighter skin types.Molecular basis of basal cell carcinoma.Histological and immunohistochemical evaluation of basal cell carcinoma following curettage and electrodessication.Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC.A nodule on the ear with unique histological features.Expression of beta-catenin in basal cell carcinoma.Basal cell carcinomas in a tertiary referral centre: a systematic analysis.Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.Comparison of clinical and histopathological evaluations of basal cell carcinoma thickness.
P2860
Q28273436-935C3F5C-AB48-4981-B5BC-B473EB6EEF3CQ30319925-AD75C417-F6C0-4FCB-974C-AABFAE9D9837Q33331965-C7C13910-C1C6-4E4A-938B-AA086964A320Q33333566-3B148951-A148-4C4F-BAD8-6556C7825BFBQ33594182-3E5D5AA9-BF2A-40D2-B7E4-B731D795796EQ34041595-901D827C-4773-4C4F-B7D8-902196C3E1D0Q34122334-DB2E8C18-A491-4614-9920-606444EEFF6CQ34199556-07AE3137-99AE-431E-B8FF-FFAECB42ABB8Q34345881-EF502235-E9D0-4D55-9EA6-97BD52F84429Q35067052-D69A9825-6715-49E2-B8E4-C449F6B04F10Q35771697-466C3E82-4AC8-4B52-8846-6A12FB49939FQ35891714-38CCCD0E-9219-4835-8B49-3F69528DCEA6Q36158929-BFD30312-1CB8-45EC-A7C4-C86C8452AE09Q36365397-1021FE44-66F9-48C4-B1A4-BF63D73746F2Q36473904-0BD9B39B-3529-4D05-9D89-63139C16FE40Q37205982-B38F6329-563E-4FAD-BA86-2864EA356903Q37450046-5B9E0C05-896A-4FE2-AF82-B88D07946BD8Q37601921-04E47FC6-22FB-4C8D-B87B-0F22C031A9D2Q37856435-390F4585-2016-40BF-B828-80BABCAFC1EAQ38363378-59906F64-A0C9-48C1-8BF7-C2E56CE2CADCQ38463991-6E0F1EA6-F940-4667-A10A-81AB1DD260D4Q38544525-B7AD5BE6-03DC-46C5-8FAA-DF1AED7E8C6EQ38735964-BD0B8B02-8FAB-490A-A3D1-D25ADB943710Q39030031-B1308578-DDAD-4D7A-BA8F-70C3BFCCA10DQ39622589-D0C09E2A-57A3-43E7-B03B-CE099B59141EQ39644046-A2A9C828-95AA-4418-AF12-57CF0C30805FQ39750493-1F8930C8-1E93-4DD0-B1A4-F6CFB5C136C9Q40011002-0D890755-0742-4F9C-AB3E-BD5925F4991CQ40140924-ED16C958-3A5C-44BD-9975-8ECE8863FD99Q40209236-583E2869-D382-4224-8FE4-F35E06BE543FQ40884294-5F640AB8-5340-464E-A606-3563E6EF051AQ41680016-E8E01997-4ADD-4FE1-A955-DCAF753E1CB7Q42436044-691859FC-A4BB-4ED3-93C2-2FF5C93206F9Q42437852-CD1CD82D-6DFF-408A-91A7-5E8128595D06Q42437894-AE8184FD-5706-425A-A89C-BDE0DDD50F0DQ42442379-7C16F0CB-1BB7-4A25-A671-1C14059F3AFAQ42461410-D58361F1-E905-44EA-B436-5D61917419BEQ42467025-3C9A0F14-C571-4FF1-BB8F-630A61AD462FQ42467845-F8F4318C-419F-4B15-AB3B-33CC95BA6989Q42472329-EB266910-AA90-410F-A4A6-E5420CB50FEB
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Why classify basal cell carcinomas?
@en
Why classify basal cell carcinomas?
@nl
type
label
Why classify basal cell carcinomas?
@en
Why classify basal cell carcinomas?
@nl
prefLabel
Why classify basal cell carcinomas?
@en
Why classify basal cell carcinomas?
@nl
P2860
P1433
P1476
Why classify basal cell carcinomas?
@en
P2093
P2860
P304
P356
10.1046/J.1365-2559.1998.00431.X
P577
1998-05-01T00:00:00Z